Skip to content

Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair

Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939652
Enrollment
60
Registered
2013-09-11
Start date
2009-02-28
Completion date
2013-07-31
Last updated
2013-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm > 5.5 cm Effect of a Restricted Intravenous Fluid Regime on Complications and Hospital Stay After the Minilaparotomy AAA Repair.

Keywords

minilaparotomy, AAA, fluid regime

Brief summary

Elective minilaparatomy abdominal aortic aneurysm (AAA) repair is associated with a significant number of complications involving respiratory, cardiovascular, gastrointestinal and central nervous system, and mortality ranging up to 5%. In our study, we tested the hypothesis that intraoperative and postoperative intravenous restrictive fluid regime reduces postoperative morbidity and mortality and improves the outcome of the treatment of minilaparotomy AAA repair.

Detailed description

We investigate effects of a restricted fluid regime versus standard regimen on complications and hospital stay after minilaparatomy aortic aneurysm repair.

Interventions

PROCEDURERestrictive VS Standard Fluid Regime
DRUGDrag: Crystalloids and Colloids

Sponsors

University Clinical Center Tuzla
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* AAA more than 5,5 cm in diameter tube graft

Exclusion criteria

* emargency comorbidity maligancy

Design outcomes

Primary

MeasureTime frame
Number of major and minor complications30 days

Secondary

MeasureTime frame
ICU and duration of Hospital stay30 days
In-hospital mortality, 30-days mortality30 days
Fluid balance (daily and cumulative)3 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026